| 000 | 01456 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515191345.0 | ||
| 264 | 0 | _c20091215 | |
| 008 | 200912s 0 0 eng d | ||
| 022 | _a1549-490X | ||
| 024 | 7 |
_a10.1634/theoncologist.2009-0026 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHurwitz, Jane L | |
| 245 | 0 | 0 |
_aNew advances in the second-line treatment of small cell lung cancer. _h[electronic resource] |
| 260 |
_bThe oncologist _cOct 2009 |
||
| 300 |
_a986-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aSmall Cell Lung Carcinoma _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTopotecan _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMcCoy, Francis | |
| 700 | 1 | _aScullin, Paula | |
| 700 | 1 | _aFennell, Dean A | |
| 773 | 0 |
_tThe oncologist _gvol. 14 _gno. 10 _gp. 986-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1634/theoncologist.2009-0026 _zAvailable from publisher's website |
| 999 |
_c19213678 _d19213678 |
||